Funding for this research was provided by:
Canadian Partnership Against Cancer (0)
Received: 2 March 2020
Accepted: 4 June 2020
First Online: 17 June 2020
Ethics approval and consent to participate
: Ethics approval for a multi-site study was obtained from the University Health Network Research Ethic Board (REB) (REB #14–8525-CE) followed by approvals in all participating regional cancer centres in Ontario and Quebec.
: Not applicable.
: Doris Howell is a member of the Scientific Advisory Board and has received fees for consultation to CAREVIVE Inc. No other conflicts of interest are declared. The content of the manuscript was not influenced by the funder.